PLoS ONE · 2014 · 23 citations · 17 references
Life SciencesCell BiologyGeneticsBiochemical GeneticsCellular MetabolismRedox BiochemistryAnemiaAntioxidant DefenseOxidative StressReactive Oxygen SpeciesRed Blood Cell DisordersRedox MetabolismAntioxidant TreatmentCellular Redox ImbalanceChromosome InstabilityComplementationDisorderFanconi Anemia PathophysiologyRed Blood Cell Antioxidant DefenseRed Blood Cell Metabolism
Fanconi anemia (FA) is a genetic disorder characterised by chromosome instability, cytokine ipersensibility, bone marrow failure and abnormal haematopoiesis associated with acute myelogenous leukemia. Recent reports are contributing to characterize the peculiar FA metabolism. Central to these considerations appears that cells from complementation group A (FANCA) display an altered red-ox metabolism. Consequently the possibility to improve FA phenotypical conditions with antioxidants is considered. We have characterized from the structural and biochemical point of view the response of FANCA lymphocytes to N-acetyl-cysteine (NAC) and resveratrol (RV). Surprisingly both NAC and RV failed to revert all the characteristic of FA phenotype and moreover their effects are not super imposable. Our data suggest that we must be aware of the biological effects coming from antioxidant treatment.
17
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations
María Castellà, Roser Pujol, Elsa Callén et al. · Blood · 2011 · 139 citations
Life Sciences, Genetics, Hematology +15